Nature Reviews Cancer

Papers
(The H4-Index of Nature Reviews Cancer is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Computing brain metastasis impact1665
Digging for treasures in the tumour interactome1205
An inhospitable site999
Fructose takes a detour to feed cancer624
Implementing practice-changing progress for managing cancer of unknown primary583
Exploiting metabolic cell death for cancer therapy565
Oncofetal reprogramming in tumour development and progression388
INVADEseq to study the intratumoural microbiota at host single-cell resolution387
Emerging strategies to investigate the biology of early cancer377
Combining spatial transcriptomics and AI to enhance brain tumour diagnosis362
Combinatorial strategies to target RAS-driven cancers353
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment331
How medical anthropology can contribute to cancer research325
Mapping the prostate cell family tree323
Fighting cancer with fat317
Reply to ‘Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies’286
3D chromatin architecture as a predictor of somatic mutations in cancer genomes281
Author Correction: Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma263
Connie J. Eaves (1944–2024)259
Antihistamines boost immunotherapy251
The evolution of cancer and ageing: a history of constraint235
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies227
The recruitment of metastasis-associated monocytes215
Translating premalignant biology to accelerate non-small-cell lung cancer interception208
Context-dependent functions of pattern recognition receptors in cancer205
Epithelial and stromal co-evolution and complicity in pancreatic cancer204
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel201
Gut microbes produce novel genotoxic metabolites197
Tertiary lymphoid structures as hubs of antitumour immunity197
No mutation, tumour initiation195
Nanoreceptors take down mutant p53192
Impersonating neurons187
Dendritic cells rise and shine186
Tumour EVPs disrupt liver function182
AACR 2025173
Measuring HLA disruption using MHC Hammer167
Persistence is key166
Thelpers? More like Ttroublemakers160
Removing barriers to address sex differences in anticancer drug toxicity158
Remodelling of the tumour microenvironment by the kallikrein-related peptidases156
Moonlighting functions of glucose metabolic enzymes and metabolites in cancer149
Defining a ‘cells to society’ research framework for appendiceal tumours146
3D bioprinted cancer models: from basic biology to drug development140
How chemokines organize the tumour microenvironment136
Natural killer cells in antitumour adoptive cell immunotherapy130
Bone voyage: immune crosstalk sets sail128
B-ring sterols to the rescue126
In-depth organoid profiling of pancreatic cancer123
Visualizing intratumoural heterogeneity with EpicMIBI122
Identifying spatial cellular structures with SPACE-GM120
The path to leptomeningeal metastasis117
Points of entry for tumour-infiltrating lymphocytes116
Regulatory T cells in the tumour microenvironment115
Environmental endocrine disruptors: rethinking the origins of early-onset ER+ breast cancer115
Un-Fair Skin: racial disparities in acral melanoma research112
The immune microenvironment of colorectal cancer112
Metabolic interplays between the tumour and the host shape the tumour macroenvironment108
Dynamics and specificities of T cells in cancer immunotherapy107
Leveraging the replication stress response to optimize cancer therapy107
Linking cell mechanical memory and cancer metastasis103
In situ decellularization of tissues to resolve the tumour-associated matrix100
Understanding and addressing race disparities in childhood cancer outcomes97
Race influences the tumour microbiome97
Encoding spatial tumour dynamics with Starfysh97
Deciphering the cancer genome and epigenome96
The link between vitamin D and prostate cancer91
Taming TAMs in brain metastases89
Don’t blame the messenger: lessons learned for cancer mRNA vaccines during the COVID-19 pandemic88
Cancer nanomedicine84
Polygenic scores in cancer83
Acetyl-CoA metabolism in cancer82
RNA splicing dysregulation and the hallmarks of cancer82
Targeted protein degradation for cancer therapy81
Z-nucleic acids give immunotherapy a boost78
Local CAR manufacturing75
2.1433341503143